annual CAPEX:
$1.92M+$101.00K(+5.56%)Summary
- As of today (July 4, 2025), CLDX annual capital expenditures is $1.92 million, with the most recent change of +$101.00 thousand (+5.56%) on December 31, 2024.
- During the last 3 years, CLDX annual CAPEX has risen by +$670.00 thousand (+53.64%).
- CLDX annual CAPEX is now -60.64% below its all-time high of $4.88 million, reached on December 31, 2015.
Performance
CLDX CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$265.00K-$491.00K(-64.95%)Summary
- As of today (July 4, 2025), CLDX quarterly capital expenditures is $265.00 thousand, with the most recent change of -$491.00 thousand (-64.95%) on March 31, 2025.
- Over the past year, CLDX quarterly CAPEX has dropped by -$79.00 thousand (-22.97%).
- CLDX quarterly CAPEX is now -92.11% below its all-time high of $3.36 million, reached on June 30, 2007.
Performance
CLDX quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$1.84M-$79.00K(-4.12%)Summary
- As of today (July 4, 2025), CLDX TTM capital expenditures is $1.84 million, with the most recent change of -$79.00 thousand (-4.12%) on March 31, 2025.
- Over the past year, CLDX TTM CAPEX has increased by +$263.00 thousand (+16.68%).
- CLDX TTM CAPEX is now -62.26% below its all-time high of $4.88 million, reached on December 31, 2015.
Performance
CLDX TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
CLDX CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +5.6% | -23.0% | +16.7% |
| 3 y3 years | +53.6% | -53.9% | +46.4% |
| 5 y5 years | +162.5% | +12.8% | +32.2% |
CLDX CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +53.6% | -65.0% | +68.8% | -5.5% | +32.7% |
| 5 y | 5-year | at high | +162.5% | -70.9% | +85.3% | -5.5% | +64.7% |
| alltime | all time | -60.6% | +2448.5% | -92.1% | +107.9% | -62.3% | +161.4% |
CLDX CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | $265.00K(-64.9%) | $1.84M(-4.1%) |
| Dec 2024 | $1.92M(+5.6%) | $756.00K(+38.7%) | $1.92M(+4.9%) |
| Sep 2024 | - | $545.00K(+98.9%) | $1.83M(+26.9%) |
| Jun 2024 | - | $274.00K(-20.3%) | $1.44M(-8.6%) |
| Mar 2024 | - | $344.00K(-48.3%) | $1.58M(-13.3%) |
| Dec 2023 | $1.82M(-0.5%) | $666.00K(+324.2%) | $1.82M(+31.1%) |
| Sep 2023 | - | $157.00K(-61.7%) | $1.39M(-11.9%) |
| Jun 2023 | - | $410.00K(-29.9%) | $1.57M(-14.3%) |
| Mar 2023 | - | $585.00K(+148.9%) | $1.84M(+0.5%) |
| Dec 2022 | $1.83M(+46.4%) | $235.00K(-31.9%) | $1.83M(-6.1%) |
| Sep 2022 | - | $345.00K(-48.7%) | $1.95M(+9.0%) |
| Jun 2022 | - | $673.00K(+17.0%) | $1.79M(+42.2%) |
| Mar 2022 | - | $575.00K(+62.4%) | $1.26M(+0.6%) |
| Dec 2021 | $1.25M(-19.5%) | $354.00K(+91.4%) | $1.25M(+9.4%) |
| Sep 2021 | - | $185.00K(+29.4%) | $1.14M(+2.2%) |
| Jun 2021 | - | $143.00K(-74.8%) | $1.12M(-40.7%) |
| Mar 2021 | - | $567.00K(+129.6%) | $1.88M(+21.4%) |
| Dec 2020 | $1.55M(+112.3%) | $247.00K(+54.4%) | $1.55M(+10.1%) |
| Sep 2020 | - | $160.00K(-82.4%) | $1.41M(+1.3%) |
| Jun 2020 | - | $910.00K(+287.2%) | $1.39M(+78.5%) |
| Mar 2020 | - | $235.00K(+123.8%) | $780.00K(+6.7%) |
| Dec 2019 | $731.00K(-10.1%) | $105.00K(-26.1%) | $731.00K(-7.2%) |
| Sep 2019 | - | $142.00K(-52.3%) | $788.00K(+11.6%) |
| Jun 2019 | - | $298.00K(+60.2%) | $706.00K(-4.6%) |
| Mar 2019 | - | $186.00K(+14.8%) | $740.00K(-9.0%) |
| Dec 2018 | $813.00K(-54.5%) | $162.00K(+170.0%) | $813.00K(-3.3%) |
| Sep 2018 | - | $60.00K(-81.9%) | $841.00K(-20.9%) |
| Jun 2018 | - | $332.00K(+28.2%) | $1.06M(-36.5%) |
| Mar 2018 | - | $259.00K(+36.3%) | $1.67M(-6.4%) |
| Dec 2017 | $1.79M(-35.0%) | $190.00K(-32.6%) | $1.79M(-20.0%) |
| Sep 2017 | - | $282.00K(-70.1%) | $2.24M(-19.0%) |
| Jun 2017 | - | $942.00K(+151.9%) | $2.76M(+6.8%) |
| Mar 2017 | - | $374.00K(-41.4%) | $2.58M(-6.0%) |
| Dec 2016 | $2.75M(-43.6%) | $638.00K(-20.8%) | $2.75M(+9.2%) |
| Sep 2016 | - | $806.00K(+5.1%) | $2.52M(-18.0%) |
| Jun 2016 | - | $767.00K(+42.0%) | $3.08M(-20.2%) |
| Mar 2016 | - | $540.00K(+32.7%) | $3.85M(-20.9%) |
| Dec 2015 | $4.88M(+152.8%) | $407.00K(-70.1%) | $4.88M(+5.3%) |
| Sep 2015 | - | $1.36M(-12.0%) | $4.63M(+17.5%) |
| Jun 2015 | - | $1.55M(-0.9%) | $3.94M(+19.7%) |
| Mar 2015 | - | $1.56M(+857.7%) | $3.29M(+70.8%) |
| Dec 2014 | $1.93M(-54.3%) | $163.00K(-75.7%) | $1.93M(-52.8%) |
| Sep 2014 | - | $672.00K(-25.3%) | $4.08M(-7.1%) |
| Jun 2014 | - | $899.00K(+361.0%) | $4.40M(+3.4%) |
| Mar 2014 | - | $195.00K(-91.6%) | $4.25M(+0.8%) |
| Dec 2013 | $4.22M(+1292.4%) | $2.32M(+135.6%) | $4.22M(+109.8%) |
| Sep 2013 | - | $984.00K(+30.3%) | $2.01M(+83.2%) |
| Jun 2013 | - | $755.00K(+366.0%) | $1.10M(+159.6%) |
| Mar 2013 | - | $162.00K(+47.3%) | $423.00K(+39.6%) |
| Dec 2012 | $303.00K(-40.5%) | $110.00K(+54.9%) | $303.00K(+1.3%) |
| Sep 2012 | - | $71.00K(-11.3%) | $299.00K(-14.3%) |
| Jun 2012 | - | $80.00K(+90.5%) | $349.00K(0.0%) |
| Mar 2012 | - | $42.00K(-60.4%) | $349.00K(-31.4%) |
| Dec 2011 | $509.00K(-75.8%) | $106.00K(-12.4%) | $509.00K(-39.5%) |
| Sep 2011 | - | $121.00K(+51.2%) | $841.00K(-32.9%) |
| Jun 2011 | - | $80.00K(-60.4%) | $1.25M(-34.7%) |
| Mar 2011 | - | $202.00K(-53.9%) | $1.92M(-8.7%) |
| Dec 2010 | $2.10M(+297.7%) | $438.00K(-17.8%) | $2.10M(+20.0%) |
| Sep 2010 | - | $533.00K(-28.5%) | $1.75M(+31.4%) |
| Jun 2010 | - | $745.00K(+94.0%) | $1.33M(+72.5%) |
| Mar 2010 | - | $384.00K(+336.4%) | $772.00K(+46.2%) |
| Dec 2009 | $528.00K(-59.5%) | $88.00K(-23.5%) | $528.00K(+13.1%) |
| Sep 2009 | - | $115.00K(-37.8%) | $467.00K(-62.1%) |
| Jun 2009 | - | $185.00K(+32.1%) | $1.23M(-13.9%) |
| Mar 2009 | - | $140.00K(+418.5%) | $1.43M(+9.8%) |
| Dec 2008 | $1.30M | $27.00K(-96.9%) | $1.30M(+1.9%) |
| Sep 2008 | - | $881.00K(+129.1%) | $1.28M(-143.5%) |
| Jun 2008 | - | $384.50K(+2976.0%) | -$2.94M(<-9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | $12.50K(+420.8%) | $29.90K(-60.3%) |
| Dec 2007 | $75.30K(-97.0%) | $2400.00(-100.1%) | $75.40K(-102.5%) |
| Sep 2007 | - | -$3.34M(-199.6%) | -$3.00M(-193.0%) |
| Jun 2007 | - | $3.36M(+5691.6%) | $3.22M(+74.0%) |
| Mar 2007 | - | $58.00K(-101.9%) | $1.85M(-25.3%) |
| Dec 2006 | $2.48M(+336.6%) | -$3.07M(-206.7%) | $2.48M(-41.0%) |
| Sep 2006 | - | $2.88M(+44.7%) | $4.20M(+125.8%) |
| Jun 2006 | - | $1.99M(+190.5%) | $1.86M(+472.7%) |
| Mar 2006 | - | $684.40K(-150.7%) | $324.70K(>+9900.0%) |
| Dec 2005 | - | -$1.35M(-351.0%) | $0.00(-100.0%) |
| Sep 2005 | - | $538.30K(+18.8%) | -$206.60K(-150.2%) |
| Jun 2005 | - | $453.20K(+26.0%) | $411.90K(+256.9%) |
| Mar 2005 | - | $359.70K(-123.1%) | $115.40K(>+9900.0%) |
| Dec 2004 | - | -$1.56M(-234.7%) | $0.00(-100.0%) |
| Sep 2004 | - | $1.16M(+638.2%) | $1.39M(+471.8%) |
| Jun 2004 | - | $156.70K(-35.9%) | $243.10K(+68.9%) |
| Mar 2004 | - | $244.30K(-245.6%) | $143.90K(>+9900.0%) |
| Dec 2003 | - | -$167.80K(-1794.9%) | $0.00(-100.0%) |
| Sep 2003 | - | $9900.00(-82.8%) | $343.50K(-10.6%) |
| Jun 2003 | - | $57.50K(-42.7%) | $384.30K(-20.4%) |
| Mar 2003 | - | $100.40K(-42.9%) | $482.90K(-14.9%) |
| Dec 2002 | $567.70K(-6.2%) | $175.70K(+246.5%) | $567.70K(+5.0%) |
| Sep 2002 | - | $50.70K(-67.5%) | $540.90K(-42.9%) |
| Jun 2002 | - | $156.10K(-15.7%) | $946.50K(+30.8%) |
| Mar 2002 | - | $185.20K(+24.4%) | $723.50K(+19.5%) |
| Dec 2001 | $605.20K(+241.5%) | $148.90K(-67.4%) | $605.20K(+19.1%) |
| Sep 2001 | - | $456.30K(-782.1%) | $508.20K(+468.5%) |
| Jun 2001 | - | -$66.90K(-200.0%) | $89.40K(-54.9%) |
| Mar 2001 | - | $66.90K(+28.9%) | $198.40K(+12.0%) |
| Dec 2000 | $177.20K(-74.3%) | $51.90K(+38.4%) | $177.20K(-17.1%) |
| Sep 2000 | - | $37.50K(-10.9%) | $213.80K(+21.3%) |
| Jun 2000 | - | $42.10K(-7.9%) | $176.30K(-24.7%) |
| Mar 2000 | - | $45.70K(-48.4%) | $234.20K(-66.0%) |
| Dec 1999 | $688.50K(+129.5%) | $88.50K(>+9900.0%) | $688.50K(-13.9%) |
| Sep 1999 | - | $0.00(-100.0%) | $800.00K(0.0%) |
| Jun 1999 | - | $100.00K(-80.0%) | $800.00K(0.0%) |
| Mar 1999 | - | $500.00K(+150.0%) | $800.00K(+166.7%) |
| Dec 1998 | $300.00K(+200.0%) | $200.00K(>+9900.0%) | $300.00K(+200.0%) |
| Sep 1998 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Jun 1998 | - | $100.00K(>+9900.0%) | $100.00K(0.0%) |
| Dec 1997 | $100.00K(-83.3%) | $0.00(0.0%) | $100.00K(-85.7%) |
| Sep 1997 | - | $0.00(-100.0%) | $700.00K(+75.0%) |
| Jun 1997 | - | $100.00K(-83.3%) | $400.00K(-33.3%) |
| Dec 1996 | $600.00K(0.0%) | $600.00K(-300.0%) | $600.00K(-700.0%) |
| Sep 1996 | - | -$300.00K(-57.1%) | -$100.00K(-111.1%) |
| Jun 1996 | - | -$700.00K(-170.0%) | $900.00K(-43.8%) |
| Mar 1996 | - | $1.00M(-1100.0%) | $1.60M(+166.7%) |
| Dec 1995 | $600.00K(-25.0%) | -$100.00K(-114.3%) | $600.00K(-14.3%) |
| Sep 1995 | - | $700.00K(>+9900.0%) | $700.00K(-12.5%) |
| Dec 1994 | $800.00K(+60.0%) | $0.00(-100.0%) | $800.00K(0.0%) |
| Sep 1994 | - | $100.00K(-80.0%) | $800.00K(-11.1%) |
| Jun 1994 | - | $500.00K(+150.0%) | $900.00K(+80.0%) |
| Mar 1994 | - | $200.00K(>+9900.0%) | $500.00K(0.0%) |
| Dec 1993 | $500.00K(0.0%) | $0.00(-100.0%) | $500.00K(0.0%) |
| Sep 1993 | - | $200.00K(+100.0%) | $500.00K(+25.0%) |
| Jun 1993 | - | $100.00K(-50.0%) | $400.00K(-33.3%) |
| Mar 1993 | - | $200.00K(+100.0%) | $600.00K(-14.3%) |
| Dec 1992 | $500.00K(+25.0%) | - | - |
| Oct 1992 | - | $100.00K(-66.7%) | $700.00K(0.0%) |
| Jul 1992 | - | $300.00K(+50.0%) | $700.00K(+75.0%) |
| Apr 1992 | - | $200.00K(+100.0%) | $400.00K(+33.3%) |
| Apr 1992 | $400.00K(0.0%) | - | - |
| Jan 1992 | - | $100.00K(0.0%) | $300.00K(-25.0%) |
| Oct 1991 | - | $100.00K(0.0%) | $400.00K(0.0%) |
| Apr 1991 | $400.00K(-42.9%) | $100.00K(-50.0%) | $400.00K(+33.3%) |
| Jan 1991 | - | $200.00K(>+9900.0%) | $300.00K(+200.0%) |
| Oct 1990 | - | $0.00(-100.0%) | $100.00K(0.0%) |
| Jul 1990 | - | $100.00K | $100.00K |
| Apr 1990 | $700.00K | - | - |
FAQ
- What is Celldex Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics annual CAPEX year-on-year change?
- What is Celldex Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly CAPEX year-on-year change?
- What is Celldex Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Celldex Therapeutics?
- What is Celldex Therapeutics TTM CAPEX year-on-year change?
What is Celldex Therapeutics annual capital expenditures?
The current annual CAPEX of CLDX is $1.92M
What is the all time high annual CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high annual capital expenditures is $4.88M
What is Celldex Therapeutics annual CAPEX year-on-year change?
Over the past year, CLDX annual capital expenditures has changed by +$101.00K (+5.56%)
What is Celldex Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of CLDX is $265.00K
What is the all time high quarterly CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly capital expenditures is $3.36M
What is Celldex Therapeutics quarterly CAPEX year-on-year change?
Over the past year, CLDX quarterly capital expenditures has changed by -$79.00K (-22.97%)
What is Celldex Therapeutics TTM capital expenditures?
The current TTM CAPEX of CLDX is $1.84M
What is the all time high TTM CAPEX for Celldex Therapeutics?
Celldex Therapeutics all-time high TTM capital expenditures is $4.88M
What is Celldex Therapeutics TTM CAPEX year-on-year change?
Over the past year, CLDX TTM capital expenditures has changed by +$263.00K (+16.68%)